{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for adenosine in root_modifications_structuralModifications_molecularFragment_refPname (approximate match)
Showing 1 - 9 of 9 results
Status:
US Approved Rx
(2021)
Source:
NDA213026
(2021)
Source URL:
First approved in 2021
Source:
NDA213026
Source URL:
Class:
NUCLEIC ACID
Status:
US Approved Rx
(2019)
Source:
NDA211970
(2019)
Source URL:
First approved in 2019
Source:
NDA211970
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT00048321: Phase 2 Interventional Completed Rheumatoid Arthritis
(2002)
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT04140539: Phase 2/Phase 3 Interventional Withdrawn Severe Combined Immunodeficiency Due to ADA Deficiency
(2019)
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Investigational
Class:
NUCLEIC ACID
Status:
Investigational
Source:
INN:zilebesiran [INN]
Source URL:
Class:
NUCLEIC ACID
Status:
Investigational
Source:
NCT03373786: Phase 1 Interventional Completed Alport Syndrome
(2017)
Source URL:
Class:
NUCLEIC ACID